Skip to content

TTF-1 + Napsin A (RM) API3078DSAA

by Biocare Medical, LLC

Ref API3078DSAA

TTF-1 + Napsin A (RM) API3078DSAA is a multiple solid tumour differentiation marker IVD (EU IVDD general IVD; FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Biocare Medical, LLC, registered in EUDAMED on 31 Aug 2026 (Basic UDI-DI B-00847627004109) and listed in FDA GUDID since 7 Dec 2022 (UDI-DI 00847627004109), active as of 23 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00847627004109 Basic UDI-DI 00847627004109UDI-DIDate31 Aug 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00847627004109 UDI-DI Date7 Dec 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00847627004109 registered 31 Aug 2026 Active
  • FDA GUDID UDI-DI 00847627004109 listed 7 Dec 2022 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00847627004109
  2. Registered EUDAMED B-00847627004109

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
TTF-1 + Napsin A (RM)
Generic name
Multiple solid tumour differentiation marker IVD, antibody
Model / reference
API3078DSAA
Primary DI / UDI-DI
00847627004109
Basic UDI-DI
B-00847627004109
FDA product code
NJT
EMDN code
W0102039099 Tumour markers - other
GMDN term
Multiple solid tumour differentiation marker IVD, antibody
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
864.1860
EU registration type
Legacy device (under a directive)
EU market of registration
Hungary
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under TUMOUR MARKERS - OTHER.

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)